Question 1

What is the catalog number for Human Monoclonal Proprotein Convertase 9/PCSK9 Antibody (RG7652) [Janelia Fluor 585]?

Accepted Answer

The catalog number for Human Monoclonal Proprotein Convertase 9/PCSK9 Antibody (RG7652) [Janelia Fluor 585] is NBP3-28201JF585.

Question 2

What sizes are available for Human Monoclonal Proprotein Convertase 9/PCSK9 Antibody (RG7652) [Janelia Fluor 585]?

Accepted Answer

Human Monoclonal Proprotein Convertase 9/PCSK9 Antibody (RG7652) [Janelia Fluor 585] is available in the following size(s): 0.1 mL.

Question 3

Is Human Monoclonal Proprotein Convertase 9/PCSK9 Antibody (RG7652) [Janelia Fluor 585] in stock?

Accepted Answer

Human Monoclonal Proprotein Convertase 9/PCSK9 Antibody (RG7652) [Janelia Fluor 585] is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Question 5

How many freeze-thaw cycles can this product tolerate?

Accepted Answer

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

Question 6

Is antigen retrieval required for IHC with this antibody?

Accepted Answer

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.

Human Monoclonal Proprotein Convertase 9/PCSK9 Antibody (RG7652) [Janelia Fluor 585]

Product Specifications

Frequently Asked Questions

Explore Other Products

Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy) (DMD/3245), Biotin conjugate, 0.1mg/mL

CD43 (SPN/839), CF405S conjugate, 0.1mg/mL

CD44v4 (Marker of Tumor Metastasis), CF488A conjugate, 0.1mg/mL

P21 / WAF1 (CIP1/823 + DCS-60.2), 1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2743), CF568 conjugate, 0.1mg/mL

CD68 (Macrophage Marker) (LAMP4/1830), CF640R conjugate, 0.1mg/mL